Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 3
2013 4
2014 1
2015 1
2017 2
2021 3
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Forkhead Box I1 in Breast Carcinoma as a Potent Prognostic Factor.
Onodera Y, Takagi K, Neoi Y, Sato A, Yamaguchi M, Miki Y, Ebata A, Miyashita M, Sasano H, Suzuki T. Onodera Y, et al. Among authors: ebata a. Acta Histochem Cytochem. 2021 Aug 25;54(4):123-130. doi: 10.1267/ahc.21-00034. Epub 2021 Jul 31. Acta Histochem Cytochem. 2021. PMID: 34511651 Free PMC article.
Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer.
Shindo H, Harada-Shoji N, Ebata A, Sato M, Soga T, Miyashita M, Tada H, Kawai M, Kosaka S, Onuki K, Usami S, Furumoto S, Hayashi S, Abe T, Suzuki T, Ishida T, Sasano H. Shindo H, et al. Among authors: ebata a. Cancers (Basel). 2021 Aug 30;13(17):4375. doi: 10.3390/cancers13174375. Cancers (Basel). 2021. PMID: 34503187 Free PMC article.
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma.
Nakagawa S, Miyashita M, Maeda I, Goda A, Tada H, Amari M, Kojima Y, Tsugawa K, Ohi Y, Sagara Y, Sato M, Ebata A, Harada-Shoji N, Suzuki T, Nakanishi M, Ohta T, Ishida T. Nakagawa S, et al. Among authors: ebata a. Breast Cancer Res Treat. 2024 Apr;204(3):453-463. doi: 10.1007/s10549-023-07209-2. Epub 2024 Jan 5. Breast Cancer Res Treat. 2024. PMID: 38180699 Free PMC article.
Establishment of an analytical method for simultaneous quantitation of CDK4/6 inhibitors, aromatase inhibitors, and an estrogen receptor antagonist in human plasma using LC-ESI-MS/MS.
Sato Y, Shigeta K, Hirasawa T, Sato T, Ogura J, Maekawa M, Ebata A, Hamanaka Y, Tada H, Ishida T, Kikuchi M, Mano N. Sato Y, et al. Among authors: ebata a. J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Mar 22;1173:122655. doi: 10.1016/j.jchromb.2021.122655. Online ahead of print. J Chromatogr B Analyt Technol Biomed Life Sci. 2021. PMID: 33831689
18 results